Safety and activity of nivolumab (nivo) monotherapy and nivo in combination with ipilimumab (ipi) in recurrent glioblastoma (GBM): Updated results from checkmate-143.

被引：49
|
作者：
Reardon, David A.
Sampson, John H.
Sahebjam, Solmaz
Lim, Michael
Baehring, Joachim M.
Vlahovic, Gordana
Cloughesy, Timothy Francis
Strauss, Lewis C.
Latek, Robert Raymond
Paliwal, Prashni
Harbison, Christopher T.
Voloschin, Alfredo Daniel
Omuro, Antonio Marcilio Padula
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.2014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2014
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Age-dependent Efficacy and Safety of Nivolumab (NIVO) as Monotherapy or Combination Therapy with Ipilimumab (NIVO plus IPI) in Patients with advanced Melanoma in the non-interventional Study (NIS) NICO
    Schadendorf, D.
    Ugurel, S.
    Eigentler, T.
    Mohr, P.
    Wei-Chenthal, M.
    Gebhardt, C.
    Goppner, D.
    Haferkamp, S.
    Herbst, R.
    Kahler, K.
    Kreuter, A.
    Meier, F.
    Pfohler, C.
    Sachse, M. M.
    Sickmann, T.
    Terheyden, P.
    Ulrich, J.
    Utikal, J. S.
    Grimmel-Mann, I.
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 16 - 17
  • [22] Nivolumab (NIVO) plus ipilimumab (IPI) plus cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040
    Yau, Thomas
    Zagonel, Vittorina
    Santoro, Armando
    Acosta-Rivera, Mirelis
    Choo, Su Pin
    Matilla, Ana
    He, Aiwu Ruth
    Gracian, Antonio Cubillo
    El-Khoueiry, Anthony B.
    Sangro, Bruno
    Eldawy, Tarek
    Bruix, Jordi
    Frassineti, Giovanni
    Vaccaro, Gina M.
    Tschaika, Marina
    Scheffold, Christian
    Shen, Yun
    Neely, Jaclyn
    Piscaglia, Fabio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [23] Updated results from a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067).
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Rutkowski, Piotr
    Grob, Jean Jacques
    Cowey, C. Lance
    Lao, Christopher
    Schadendorf, Dirk
    Ferrucci, Pier Francesco
    Smylie, Michael
    Dummer, Reinhard
    Hill, Andrew
    Haanen, John B. A. G.
    Maio, Michele
    McArthur, Grant A.
    Walker, Dana
    Jiang, Joel
    Horak, Christine E.
    Larkin, James M. G.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] A multi-center phase II open-label study (CheckMate 204) to evaluate safety and efficacy of nivolumab (NIVO) in combination with ipilimumab (IPI) followed by NIVO monotherapy in patients (pts) with melanoma (MEL) metastatic to the brain.
    Margolin, Kim Allyson
    Tawbi, Hussein Abdul-Hassan
    Ernstoff, Marc S.
    Hodi, F. Stephen
    McDermott, David F.
    Edwards, Robin
    Avila, Alexandre
    Atkins, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] ASSESSMENT OF THE IMMUNOGENICITY OF NIVOLUMAB (NIVO) AND IPILIMUMAB (IPI) IN COMBINATION AND POTENTIAL IMPACT ON SAFETY AND EFFICACY IN PATIENTS WITH ADVANCED MELANOMA
    Statkevich, P.
    Passey, C.
    Park, J.
    Saeger, S.
    Bello, A.
    Roy, A.
    Agrawal, S.
    Gupta, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S64 - S64
  • [26] Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Subgroup analyses from CheckMate 040
    He, Aiwu Ruth
    Yau, Thomas
    Hsu, Chiun
    Kang, Yoon-Koo
    Kim, Tae-You
    Santoro, Armando
    Sangro, Bruno
    Melero, Ignacio
    Kudo, Masatoshi
    Hou, Ming-Mo
    Matilla, Ana
    Tovoli, Francesco
    Knox, Jennifer J.
    El-Rayes, Bassel F.
    Acosta-Rivera, Mirelis
    Neely, Jaclyn
    Shen, Yun
    Tschaika, Marina
    El-Khoueiry, Anthony B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [27] SAFETY DATA FROM AN EXPANDED ACCESS PROGRAM (EAP) OF NIVOLUMAB (NIVO) IN COMBINATION WITH IPILIMUMAB (IPI) IN PATIENTS WITH ADVANCED MELANOMA (MEL)
    Chapman, Paul B.
    Sznol, Mario
    Lao, Christopher D.
    Gonzalez, Rene
    Daniels, Gregory A.
    Thompson, John A.
    Kudchadkar, Ragini R.
    Sharfman, William H.
    Atkins, Michael B.
    Pavlick, Anna C.
    Infante, Jeffrey R.
    Kim, Kevin B.
    Weber, Jeffrey S.
    Nair, Suresh
    Cowey, Lance
    Lipson, Evan J.
    Lee, Sue
    Avila, Alexandre
    Hodi, Stephen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 119 - 119
  • [28] Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL).
    Chapman, Paul B.
    Sznol, Mario
    Lao, Christopher
    Gonzalez, Rene
    Daniels, Gregory A.
    Thompson, John A.
    Kudchadkar, Ragini Reiney
    Sharfman, William Howard
    Atkins, Michael B.
    Pavlick, Anna C.
    Infante, Jeffrey R.
    Kim, Kevin
    Weber, Jeffrey S.
    Patel, Sapna Pradyuman
    Nair, Suresh
    Cowey, C. Lance
    Lipson, Evan J.
    Lee, Sue
    Avila, Alexandre
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331
    Reck, M.
    Vicente, D.
    Ciuleanu, T.
    Gettinger, S.
    Peters, S.
    Horn, L.
    Audigier-Valette, C.
    Pardo, N.
    Juan-Vidal, O.
    Cheng, Y.
    Zhang, H.
    Shi, M.
    Wolf, J.
    Antonia, S. J.
    Nakagawa, K.
    Selvaggi, G.
    Baudelet, C.
    Chang, H.
    Spigel, D. R.
    ANNALS OF ONCOLOGY, 2018, 29 : 43 - 43
  • [30] Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204.
    Tawbi, Hussein Abdul-Hassan
    Forsyth, Peter A. J.
    Algazi, Alain Patrick
    Hamid, Omid
    Hodi, F. Stephen
    Moschos, Stergios J.
    Khushalani, Nikhil I.
    Gonzalez, Rene
    Lao, Christopher D.
    Postow, Michael Andrew
    Atkins, Michael B.
    Ernstoff, Marc S.
    Puzanov, Igor
    Kudchadkar, Ragini Reiney
    Thomas, Reena Parada
    Tarhini, Ahmad A.
    Jiang, Joel
    Avila, Alexandre
    Demelo, Sheena
    Margolin, Kim Allyson
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345